The head of the Food and Drug Administration's drug centre abruptly resigned on Sunday (November 2, 2025) after federal officials began reviewing “serious concerns about his personal conduct,” according to a government spokesperson.
Dr. George Tidmarsh, who was named to the FDA post in July, was placed on leave on Friday after officials in the Department of Health and Human Services' Office of General Counsel were notified of the issues, HHS Press Secretary Emily Hilliard said in an email. Mr.
Continue Reading on The Hindu
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.